Navigation Links
Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
Date:1/4/2012

BALTIMORE, Jan. 4, 2012 /PRNewswire/ -- Arcion Therapeutics, a clinical stage biotechnology company developing topical therapies for chronic pain, today announced that it received notice of allowance for a US Patent for its high strength gel formulation of topical lidocaine, ARC-2022.  ARC-2022 is being developed by Arcion for pain associated with post-herpetic neuralgia (PHN) and shingles.  ARC-2022 has been evaluated in a single-dose Phase 1 pharmacokinetic study in adult patients with PHN.  The results indicated sustained delivery without requirement of a patch or skin-occlusion.  No safety issues were identified.

"With ARC-2022 our goal is to deliver lidocaine to the skin without the requirement of an occlusive patch.  With topical delivery, systemic toxicities and CNS side effects can be avoided and the abnormal pain signals are suppressed at the point of origination in the skin," said James N. Campbell, MD, President and CEO of Arcion.  "Issues with presently available FDA products for the treatment of neuropathic pain include limited efficacy and frequent side effects.  Patches can pose challenges to the patient, particularly when they must be applied over joints, feet, hands, hairy or sweaty skin, or areas such as the face where aesthetics come into play.  We believe ARC-2022 is an excellent candidate to address a significant market need with a product that optimizes delivery directly to the painful skin without the need for a patch." 

"This patent allowance represents the second patent in the last three months for our two topical chronic pain programs, ARC-2022 and ARC-4558.  These products now have patent protection through 2029 and beyond," commented Kerrie Brady, COO of Arcion. "We are on track to advance ARC-4558 for painful diabetic neuropathy into Phase 3 studies and ARC-2022 into further Phase 1/2 studies in 2012. ARC-4558 has received fast-track status with the FDA."


'/>"/>

SOURCE Arcion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arcion Therapeutics to Present ARC-4558 Phase 2b Data for the Treatment of Pain Associated With Painful Diabetic Neuropathy at Upcoming Medical Meetings
2. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
3. BioNeutral Group Receives $400,000 in Equity Financing
4. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
5. Intimate Bridge 2 Conception, Inc. Receives $4.3M
6. MacroGenics Receives Milestone Payment as Part of Its Global DARTâ„¢ Alliance with Boehringer Ingelheim
7. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
8. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
9. Watsons Generic Yaz(R) Receives FDA Approval
10. UCSB professor receives award for graphene electronics research
11. iBio, Inc. Receives Notice from NYSE Amex Staff that Company Currently is Below Certain Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Foster City, CA (PRWEB) October 01, 2014 ... century, it leaves no room for doubt that this century ... and innovations in the field of medicine science. The fact ... health problems is not unknown to the scientific community. Almost ... and pollution and therefore can be prevented with medical care ...
(Date:10/1/2014)... BOSTON, MA (PRWEB) September 30, 2014 ... company, SoundConnect announces four new-hosted collaboration ... innovative bundles deliver high quality conferencing experiences for ... collaboration packages to choose from, businesses have optimized ... bundled solutions include audio only minutes ...
(Date:10/1/2014)... October 1, 2014 Industry ... invited to engage around the theme, ,Commercial Opportunities in ...   Elsevier , a world-leading ... services, will host a gathering of some of the ... trends impacting healthcare today and in the future. The ...
(Date:9/30/2014)... Pacific Northwest Biotechnology, LLC - Product ... Markets Direct,s, ,Pacific Northwest Biotechnology, LLC - Product ... the Pacific Northwest Biotechnology, LLC,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Pacific ... various stages, therapeutics assessment by drug target, mechanism ...
Breaking Biology Technology:Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 2Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 3SoundConnect Launches New Audio, Web and Video Bundles 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3
... 18, 2011 Ingenuity® Systems, a leading provider ... Erasmus Medical Center, jointly announced a scientific collaboration ... As part of the collaboration, Erasmus ... derive the most impactful biological insights from their ...
... German . , At the beginning of the ... for use of the first thiol-based self-assembling monolayers (SAMs). Nanotechnology ... now honored with the Research Award of the Alexander von ... of Functional Interfaces (IFG) at KIT and the Bielefeld Institute ...
... Jan. 14, 2011 Dendreon Corporation (Nasdaq: ... offering of $540 million aggregate principal amount of 2.875% ... in an offering registered under the Securities Act of ... from its previously announced $500 million offering.  The Notes ...
Cached Biology Technology:Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research 2New impulses for surface research 2Dendreon Announces Pricing of $540 Million Convertible Senior Notes Due 2016 2Dendreon Announces Pricing of $540 Million Convertible Senior Notes Due 2016 3Dendreon Announces Pricing of $540 Million Convertible Senior Notes Due 2016 4
(Date:9/30/2014)... DURHAM, N.C. -- Pollution in urban and farm runoff ... a new study finds. , The study, published ... shows that nitrogen in the runoff ends up in ... tumors on the animals, eyes, flippers and internal organs. ... and the National Oceanic and Atmospheric Administration (NOAA) conducted ...
(Date:9/30/2014)... your doctor to know what goes wrong with your muscles ... to know what "normal" actually is. That,s where a new ... FASEB Journal comes in. In the ... set of molecules that can help scientists "see" which genes ... more, they found never-before-detected gene activity and that men have ...
(Date:9/30/2014)... 30, 2014  Spectra Automation, a trusted ... biotech and power generation industries, announced today ... Manager, an easy-to-use and cost-effective data collection, ... development laboratories. Most upstream ... analyzer systems. Accessing and consolidating data from ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2
... been named among the nation,s most innovative users of ... has been announced and can be viewed at ... the nation,s most innovative users of information technology and ... some of the best-known organizations in the country. Past ...
... With only two weeks to go and almost a ... 2013 have reached their final stages. This year,s conference ... Simons will deliver the opening keynote lecture and explain ... cells work. In further keynote lectures, Hans Clevers will ...
... Sept. 8, 2013 An ambitious partnership among more ... & Gamble,s (P&G,s) nonprofit program, Children,s Safe ... 6 billion quarts of clean drinking water to families ... they,re just getting started. CSDW Manager Allison Tummon ...
Cached Biology News:All set for The EMBO Meeting 2013 2Water-purification plant the size of a fast-food ketchup packet saves lives 2
... I from vaccinia virus is a type ... and negative superhelical turns (also called right- ... The product of the reaction is a ... or negative superhelical turns. DNA Topoisomerase I ...
... The CpGenome Fast DNA Modification Kit contains ... on a DNA sample. In the bisulfite ... sulfonated, converting them to uracils, while 5-methylcytosines ... treated DNA will differ depending on whether ...
... Molecular Probes EnzChek Pyrophosphate Detection ... spectrophotometric,method for measuring the inorganic pyrophosphate ... biochemical reactions, such as DNA and,RNA ... enzyme,adenylate cyclase and the enzymatic activation ...
... high PCR specificity *High PCR specificity ... enzyme with unique QIAGEN PCR Buffer ... provided by the stringent built-in hot ... Master Mix and simple reaction setup ...
Biology Products: